Nuveen’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.8M Buy
521,177
+5,285
+1% +$117K ﹤0.01% 1638
2026
Q1
$12M Buy
515,892
+33,105
+7% +$1.03M ﹤0.01% 1442
2025
Q4
$21.4M Buy
482,787
+10,045
+2% +$564K 0.01% 1109
2025
Q3
$34.6M Sell
472,742
-75,154
-14% -$4.9M 0.01% 806
2025
Q2
$33.6M Sell
547,896
-38,967
-7% -$2.17M 0.01% 787
2025
Q1
$34.1M Buy
586,863
+122,205
+26% +$7.72M 0.01% 803
2024
Q4
$24.8M Buy
464,658
+150,734
+48% +$7.38M 0.01% 1030
2024
Q3
$13.7M Sell
313,924
-6,203
-2% -$207K ﹤0.01% 1425
2024
Q2
$8.95M Buy
320,127
+14,636
+5% +$386K ﹤0.01% 1643
2024
Q1
$8.22M Sell
305,491
-4,722
-2% -$135K ﹤0.01% 1723
2023
Q4
$8.7M Buy
310,213
+6,036
+2% +$143K ﹤0.01% 1680
2023
Q3
$6.45M Buy
304,177
+7,992
+3% +$218K ﹤0.01% 1741
2023
Q2
$10.1M Sell
296,185
-11,061
-4% -$368K ﹤0.01% 1505
2023
Q1
$9.95M Buy
307,246
+103
+0% +$3.42K ﹤0.01% 1484
2022
Q4
$10.3M Buy
307,143
+2,376
+0.8% +$72.6K ﹤0.01% 1466
2022
Q3
$9.21M Buy
304,767
+117,120
+62% +$4.29M ﹤0.01% 1524
2022
Q2
$6.53M Buy
+187,647
New +$7.39M ﹤0.01% 1776

Other funds holding DOCS

Nuveen's DOCS Position: Q2 2026 in Review

Nuveen increased its Doximity (DOCS) stake by 1% in Q2 2026, buying an estimated $117K and bringing the position to 521,177 shares worth $10.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1638.

Nuveen first reported a position in DOCS in Q2 2022 and has held it in 17 quarters since. The position peaked at $34.6M in Q3 2025. 358 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • Nuveen held 521,177 shares of Doximity worth $10.8M as of Q2 2026.
  • Nuveen bought 5,285 Doximity shares in Q2 2026, an estimated $117K.
  • Doximity made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1638 holding.
  • Nuveen first reported a position in Doximity in Q2 2022 and has held it in 17 quarters since.
  • Nuveen's Doximity position peaked at $34.6M in Q3 2025.
  • 358 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.